Interferon β 1a

Interferon β 1a Reactions 1680, p184 - 2 Dec 2017 Psoriasis flare and Koebner phenomenon along abdominal injection site: case report A 26-year-old woman developed psoriasis flare and Koebner phenomenon along abdominal injection site during treatment with interferon β 1a [dosage and duration of treatment to reaction onset not stated]. The woman had a history of psoriasis. Subsequently, she was diagnosed with relapsing-remitting multiple sclerosis (RRMS). As a result, she received SC injection of interferon β 1a as first-line treatment for RRMS. However, four months after the initiation, the woman’s interferon β 1a therapy was switched to oral dimethyl fumarate due to the psoriasis flare with plaques in the upper and lower extremities. Additionally, she developed Koebner phenomenon at abdominal injection sites. Within 14 months of the initiation of dimethyl fumarate, a complete remission in her psoriatic eruptions was observed along with a residual discolouration in former Koebner-positive sites. From the last 3 years, she had been receiving dimethyl fumarate without any further relapse in multiple sclerosis. Author comment: "Interferon-induced psoriasis flare in a multiple sclerosis case remits with dimethyl fumarate." "Interferon was discontinued 4 months later, following a dramatic psoriasis flare with plaques in upper and lower extremities and manifestation of Koebner phenomenon along abdominal injection sites." Tsivgoulis G, et al. Teaching Neuro Images: Interferon-induced psoriasis flare in a multiple sclerosis case remits with dimethyl fumarate. Neurology 89: e188-e189, No. 15, 10 Oct 2017. Available from: URL: WNL.0000000000004501 - Greece 803284862 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680 Reactions Weekly Springer Journals

Interferon β 1a

Reactions Weekly , Volume 1680 (1) – Dec 2, 2017
1 page

Loading next page...
1 Page
Springer International Publishing
Copyright © 2017 by Springer International Publishing AG, part of Springer Nature
Medicine & Public Health; Drug Safety and Pharmacovigilance; Pharmacology/Toxicology
Publisher site
See Article on Publisher Site


You’re reading a free preview. Subscribe to read the entire article.

DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches


Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.



billed annually
Start Free Trial

14-day Free Trial